4//SEC Filing
Schoenberg Mark 4
Accession 0001437749-25-020045
CIK 0001668243other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 9:14 AM ET
Size
8.2 KB
Accession
0001437749-25-020045
Insider Transaction Report
Form 4
Schoenberg Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2025-06-08+10,000→ 158,540 total - Exercise/Conversion
Restricted Stock Units
2025-06-08−10,000→ 10,000 total→ Ordinary Shares (10,000 underlying) - Sale
Ordinary Shares
2025-06-09$7.37/sh−5,162$38,044→ 153,378 total
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001763581
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 9:14 AM ET
- Size
- 8.2 KB